The additional value of routine electrocardiograms in cardiovascular risk management of older people

References

• Strandberg TE, Pitkala KH, Berglind S, Nieminen MS, Tilvis RS. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: The Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: A randomized, controlled trial. Am Heart J 2006; 152: 585–92
   PubMed Web of Science ®Google Scholar
• Bulpitt CJ. Secondary prevention of coronary heart disease in the elderly. Heart 2005; 91: 396–400
   PubMedGoogle Scholar
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71–86.
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002; 360: 1623–30
   PubMed Web of Science ®Google Scholar
• Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, et al. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial. Ann Intern Med 2001; 134: 931–40
   PubMed Web of Science ®Google Scholar
• Wei L, Ebrahim S, Bartlett C, Davey PD, Sullivan FM, MacDonald TM. Statin use in the secondary prevention of coronary heart disease in primary care: Cohort study and comparison of inclusion and outcome with patients in randomised trials. BMJ 2005; 330: 821
   PubMed Web of Science ®Google Scholar
• Gotto AM, Jr. Statin therapy and the elderly: SAGE Advice?. Circulation 2007; 115: 681–3
   PubMed Web of Science ®Google Scholar
• Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489–97
   PubMed Web of Science ®Google Scholar
• Fox KM, Bertrand M, Ferrari R, Remme WJ, Simoons ML, Remme WJ, et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782–8
   PubMed Web of Science ®Google Scholar
• Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH, Mohiuddin SM, et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > = 75 years of age): An American Heart Association Scientific Statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002; 105: 1735–43
   PubMed Web of Science ®Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601–10
   PubMed Web of Science ®Google Scholar
• Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update – Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363–72
   PubMed Web of Science ®Google Scholar
• Clinical Guideline A Prophylaxis for patients who have experienced a myocardial infarction. London: National Institute for Clinical Excellence; 2006.
   Google Scholar
• Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852–923
   PubMed Web of Science ®Google Scholar
• De Ruijter W, Westendorp RGJ, Macfarlane PW, Jukema JW, Assendelft WJJ, Gussekloo J. The routine electrocardiogram for cardiovascular risk stratification in old age: The Leiden 85-Plus Study. J Am Geriatr Soc 2007; 55: 872–7
   PubMedGoogle Scholar
• Sheifer SE, Gersh BJ, Yanez ND, III, Ades PA, Burke GL, Manolio TA. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000; 35: 119–26
   PubMedGoogle Scholar
• Nadelmann J, Frishman WH, Ooi WL, Tepper D, Greenberg S, Guzik H, et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. Am J Cardiol 1990; 66: 533–7
   PubMedGoogle Scholar
• Macfarlane PW, Latif S. Automated serial ECG comparison based on the Minnesota code. J Electrocardiol 1996; 29 (Suppl): 29–34
   PubMedGoogle Scholar
• Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification. Wright, Boston, MA 1982
   Google Scholar
• World Health Organization. International Classification of Diseases and Related Disorders. Geneva: World Health Organization; 2006.
   Google Scholar
• Mitka M. Electronic health records, after-hours care lag in US primary care practices. JAMA 2006; 296: 2913–4
   PubMedGoogle Scholar
• Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001; 135: 801–11
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. Circulation 1998; 98: 946–52
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983–8
   PubMed Web of Science ®Google Scholar
• O'Donnell CJ, Glynn RJ, Field TS, Averback R, Satterfield S, Friesenger GC, et al. Misclassification and under-reporting of acute myocardial infarction by elderly persons: Implications for community-based observational studies and clinical trials. J Clin Epidemiol 1999; 52: 745–51
   PubMedGoogle Scholar
• Kors JA, van Herpen G, Wu J, Zhang Z, Prineas RJ, van Bemmel JH. Validation of a new computer program for Minnesota coding. J Electrocardiol 1996; 29 (Suppl): 83–8
   PubMedGoogle Scholar
• Tuinstra CL, Rautaharju PM, Prineas RJ, Duisterhout JS. The performance of three visual coding procedures and three computer programs in classification of electrocardiograms according to the Minnesota Code. J Electrocardiol 1982; 15: 345–50
   PubMedGoogle Scholar
• Ramsay SE, Whincup PH, Lawlor DA, Papacosta O, Lennon LT, Thomas MC, et al. Secondary prevention of coronary heart disease in older patients after the national service framework: Population based study. BMJ 2006; 332: 144–5
   PubMed Web of Science ®Google Scholar
• Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ 1997; 314: 1529–30
   PubMed Web of Science ®Google Scholar
• Tran CTT, Laupacis A, Mamdani MM, Tu JV. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J 2004; 148: 834–41
   PubMedGoogle Scholar